trending Market Intelligence /marketintelligence/en/news-insights/trending/vud7daiqnibxljqbnz6sgg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Arix Bioscience CEO transitioning to chief investment officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Arix Bioscience CEO transitioning to chief investment officer

Arix Bioscience PLC said CEO Joe Anderson will become the chief investment officer.

The company added that Anderson will also step down from the board, effective Sept. 4.

Executive Chairman Jonathan Peacock will assume corporate and operating responsibilities and will work with the board to recruit a new CEO.

London-based Arix is an investment company that invests in medical innovation comprising healthcare and the life sciences.